Posted 2/29/2024, 11:00:11 PM
Aquestive Therapeutics Stock Up 50% in a Month, Analysts Optimistic About Continued Growth
- Aquestive Therapeutics (AQST) stock rose 0.55% on a day when the broader market also saw gains
- The stock has climbed over 50% in the past month, outpacing the S&P 500 and Medical sector
- AQST is expected to report improved EPS of -$0.08 and revenue growth of 10.36% in its next quarterly earnings
- Recent analyst estimate changes reflect optimism about AQST's business and profitability potential
- At present, the Medical - Drugs industry ranks in the top 39% of Zacks-covered sectors, suggesting potential for further outperformance